ACAD | ACADIA Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: San Diego, California, United States Trade prices Volume: Market Cap: 2.32B Prev closed: Open: 22.31 High: 22.91 Low: 21.38 52 week low: 15.68 52 week high: 54.58 Dividends: No Dividends Next ER: February 27, 2023 After Market Closes
About the Company Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Earnings History Date EPS / Forecast Revenue / Forecast May 3, 2023 February 27, 2023 -0.26 / -0.25136.5M / 134.23MBeat! November 2, 2022 -0.17 / -0.19130.7M / 138.64MAugust 8, 2022 -0.21 / -0.2478134.56M / 130.41MBeat! May 4, 2022 -0.7 / -0.6179115.47M / 121.91Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 8, 2022 16.62 16.14 16.96
16.14
2.06M 1.09% Aug 5, 2022 16.44 15.21 16.97
14.95
4.05M 5.25% Aug 4, 2022 15.62 15.26 15.72
14.89
1.80M 4.34% Aug 3, 2022 14.97 15.38 15.81
14.93
2.18M -0.27% Aug 2, 2022 15.01 14.08 15.06
13.80
1.43M 6.38% Aug 1, 2022 14.11 14.56 14.96
14.08
1.97M -3.95% Jul 29, 2022 14.69 14.52 14.74
14.18
1.35M 0.75% Jul 28, 2022 14.58 14.79 14.85
14.31
1.08M -1.29% Jul 27, 2022 14.77 14.21 14.80
14.05
1.34M 4.31% Jul 26, 2022 14.16 14.27 14.49
14.08
1.10M -0.49% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:1993 Employees:490 News
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for finance.yahoo.com Mar 7, 2023 10:02 am
Breakeven On The Horizon For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) finance.yahoo.com Mar 7, 2023 9:11 am Acadia Pharmaceuticals Bulls Will Need to Be Patient for Now finance.yahoo.com Mar 7, 2023 8:28 am Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines seekingalpha.com Mar 5, 2023 2:45 am Catalyst watch: General Electric, Apple, Chevron, Black Knight and Ethereum in the spotlight seekingalpha.com Mar 4, 2023 4:30 am
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2022 Earnings Call Transcript finance.yahoo.com Mar 2, 2023 5:45 am
Analysts See Steady Growth For Acadia Pharma's Nuplazid finance.yahoo.com Feb 28, 2023 4:00 pm ACADIA Pharma GAAP EPS of -$0.26 misses by $0.02, revenue of $136.49M beats by $1.31M seekingalpha.com Feb 28, 2023 5:08 am
Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Tops Revenue Estimates finance.yahoo.com Feb 27, 2023 5:25 pm
Acadia Pharmaceuticals (ACAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release finance.yahoo.com Feb 20, 2023 10:00 am
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Feb 13, 2023 4:15 pm
Investors in ACADIA Pharmaceuticals (NASDAQ:ACAD) from three years ago are still down 62%, even after 4.1% gain this past week finance.yahoo.com Jan 3, 2023 11:58 am
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences finance.yahoo.com Nov 8, 2022 4:05 pm
Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results finance.yahoo.com Nov 7, 2022 4:05 pm
Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results finance.yahoo.com Nov 7, 2022 4:05 pm
Acadia's (ACAD) Q2 Earnings & Revenues Surpass Estimates finance.yahoo.com Nov 7, 2022 11:06 am Acadia Pharmaceuticals downgraded to sell at Goldman Sachs following Q3 earnings seekingalpha.com Nov 4, 2022 9:45 pm Acadia Pharmaceuticals sees Q3 mixed bag as it beats on bottom line but misses on top seekingalpha.com Nov 3, 2022 5:08 am ACADIA Pharma GAAP EPS of -$0.17 beats by $0.02, revenue of $130.71M misses by $8.33M seekingalpha.com Nov 3, 2022 4:20 am ACADIA Pharma Q4 2022 Earnings Preview seekingalpha.com Feb 27, 2023 6:35 am This company doesn't provide a dividend.
Talk about ACADIA Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 43 HOLD 57 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis